Skip to main content

Table 1 Age distribution (at time of consent)

From: Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment

Age (years) Frequency
51–55 2 (female = 1, male = 1)
56–60 4 (female = 1, male = 3)
61–65 6 (female = 2, male = 4)
66–70 3 (female = 1, male = 2)
71–75 5 (female = 1, male = 4)
76–80 2 (male = 2)